🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/08/2016 | 59,98 | 60,21 | 59,42 | 59,47 | -0,65% | 1,32% | 8.329.190 |
| 24/08/2016 | 60,69 | 60,86 | 59,65 | 59,86 | -1,34% | 2,00% | 7.842.079 |
| 23/08/2016 | 60,79 | 60,95 | 60,47 | 60,67 | +0,05% | 0,80% | 6.076.723 |
| 22/08/2016 | 60,35 | 60,73 | 60,19 | 60,64 | +0,30% | 0,89% | 6.756.666 |
| 19/08/2016 | 60,29 | 60,53 | 59,99 | 60,46 | -0,42% | 0,90% | 8.887.040 |
| 18/08/2016 | 60,19 | 60,73 | 60,19 | 60,72 | +0,54% | 0,89% | 7.259.077 |
| 17/08/2016 | 60,14 | 60,52 | 59,73 | 60,39 | +0,40% | 1,32% | 8.668.532 |
| 16/08/2016 | 60,11 | 60,42 | 59,96 | 60,15 | -0,44% | 0,76% | 5.952.745 |
| 15/08/2016 | 60,45 | 60,83 | 60,31 | 60,42 | -0,05% | 0,85% | 6.969.305 |
| 12/08/2016 | 60,25 | 60,54 | 60,05 | 60,45 | -0,44% | 0,82% | 6.544.026 |
| 11/08/2016 | 59,74 | 60,81 | 59,62 | 60,72 | +1,58% | 2,00% | 10.862.520 |
| 10/08/2016 | 59,25 | 60,21 | 59,23 | 59,77 | +0,24% | 1,66% | 9.259.499 |
| 09/08/2016 | 59,98 | 60,25 | 59,57 | 59,63 | -0,59% | 1,13% | 12.821.651 |
| 08/08/2016 | 59,79 | 60,13 | 59,11 | 59,98 | -1,57% | 1,71% | 26.248.103 |
| 05/08/2016 | 55,19 | 61,07 | 55,19 | 60,94 | +10,41% | 10,65% | 76.374.048 |
| 04/08/2016 | 55,10 | 55,56 | 55,10 | 55,19 | +0,33% | 0,85% | 5.807.387 |
| 03/08/2016 | 55,51 | 55,63 | 54,56 | 55,01 | -1,17% | 1,93% | 10.099.890 |
| 02/08/2016 | 55,99 | 56,04 | 55,58 | 55,66 | -0,56% | 0,82% | 7.153.962 |
| 01/08/2016 | 56,14 | 56,30 | 55,82 | 55,97 | +0,00% | 0,85% | 9.297.018 |
| 29/07/2016 | 56,31 | 56,49 | 55,60 | 55,97 | +0,39% | 1,58% | 8.898.778 |
| 28/07/2016 | 55,84 | 55,91 | 55,45 | 55,75 | -0,29% | 0,82% | 7.639.606 |
| 27/07/2016 | 55,72 | 56,03 | 55,28 | 55,92 | +0,41% | 1,35% | 8.267.462 |
| 26/07/2016 | 56,01 | 56,12 | 55,48 | 55,69 | -0,34% | 1,14% | 7.494.038 |
| 25/07/2016 | 55,94 | 56,18 | 55,32 | 55,88 | -0,44% | 1,54% | 8.422.986 |
| 22/07/2016 | 56,29 | 56,37 | 55,87 | 56,13 | +0,05% | 0,90% | 6.570.436 |
| 21/07/2016 | 56,30 | 56,40 | 55,88 | 56,10 | +0,00% | 0,93% | 6.337.361 |
| 20/07/2016 | 56,30 | 56,41 | 56,07 | 56,10 | +0,22% | 0,61% | 6.786.848 |
| 19/07/2016 | 56,37 | 56,77 | 55,88 | 55,97 | -0,61% | 1,59% | 9.307.602 |
| 18/07/2016 | 56,30 | 56,77 | 56,03 | 56,32 | -1,02% | 1,31% | 9.190.122 |
| 15/07/2016 | 57,06 | 57,19 | 56,54 | 56,90 | -0,03% | 1,14% | 8.554.510 |